Mehtap Bacioglu
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Correction: Cleaved TMEM106B forms amyloid aggregates in central and peripheral nervous systems.
Journal: Acta neuropathologica communications
Published: August 13, 2024
TMEM106B amyloid filaments in the Biondi bodies of ependymal cells.
Journal: Acta neuropathologica
Published: June 18, 2024
Cleaved TMEM106B forms amyloid aggregates in central and peripheral nervous systems.
Journal: Acta neuropathologica communications
Published: June 01, 2024
Post-mortem validation of in vivo TSPO PET as a microglial biomarker.
Journal: Brain : a journal of neurology
Published: May 28, 2024
Targeting tau degradation: a viable therapeutic approach?
Journal: The Lancet. Neurology
Published: February 21, 2023
New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy.
Journal: Acta neuropathologica
Published: November 23, 2022
Signatures of glial activity can be detected in the CSF proteome.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 06, 2022
Age-dependent formation of TMEM106B amyloid filaments in human brains.
Journal: Nature
Published: November 09, 2021
LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathies.
Journal: EMBO molecular medicine
Published: June 18, 2021
Microglial inclusions and neurofilament light chain release follow neuronal α-synuclein lesions in long-term brain slice cultures.
Journal: Molecular neurodegeneration
Published: April 09, 2021
Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions.
Journal: Acta neuropathologica communications
Published: May 27, 2020
Last Updated: 09/26/2026